Diabetes Monitors Market Segmentation By Sample (Sweat, Blood, Urine & Others); By Product Type (Point Sample Test Based Glucose Monitors, Continuous Glucose Monitoring Devices, Self-Monitoring Devices, Enzyme Free Sensor Based Glucose Monitors); By Components (Glucose Test Strips, Lancet & Sensors); By End Users (Hospitals, Diagnostic Clinics & Home) - Global Demand Analysis & Opportunity Outlook 2027

Global Diabetes Monitors Market Overview

Diabetes is a combination of variety of metabolic disorders in which there is high glucose concentration in the blood. Diabetes is also known as Diabetes Mellitus.  Increase in glucose concentration often leads to different medical problems which includes increased thirst, frequent urination followed by increased hunger. This increase in the blood glucose concentration is called hyperglycemia. Diabetes takes place when the pancreas is unable to produce enough insulin or when the body does not react to insulin. Diabetes management becomes very important for people who are suffering from diabetes.

Diabetes monitors are medical instruments which monitor blood glucose concentration and among the most common methods are self-monitoring methods. In this method, a small drop of blood is taken out from the finger and is applied on the glucose test strip and a glucometer. The non- invasive glucose monitoring is done by taking other biological samples which includes sweat, urine, breath, ocular fluid or saliva. This method is called non-invasive continuous monitoring. For real time monitoring of blood glucose concentration, the Continuous Glucose Monitoring (CGM) method is adopted as it is one of the most advanced method. Self-monitoring of blood glucose is preferred widely by many diabetic patients as it is economical and less complex to use.

Market Size and Forecast

The global diabetes monitors market is observing vibrant growth on the account of increasing number of diabetic population worldwide which can be attributed to increasing obesity, age, unhealthy lifestyle and eating habits etc. Additionally, huge investment in research in the field of diabetes control and treatment combined with growing technological advancements in diabetes monitors are some of the significant factors that are also fueling the growth of the market and are further anticipated to boost the market revenue in upcoming years.

The diabetes monitor market is anticipated to record a substantial CAGR over the forecast period i.e. 2019-2027. The market is segmented on the basis of product type into point sample test based glucose monitors, continuous glucose monitoring devices, continuous glucose monitoring devices, self-monitoring devices and enzyme free sensor based glucose monitors, out of which, self-monitoring devices are expected to capture the highest market share during the forecast period. 

Get more information on this report: Download Sample PDF

Growth Drivers

Rise in Diabetic Population

There is a rise in the diabetic patient pool worldwide every year. For a diabetic patient, it is mandatory to monitor the blood glucose concentration, where diabetes monitors play an important part in monitoring it. According to International Diabetic Federation, 425 million people are suffering from diabetes across the globe with 82 million people in the Southeast Asia Region and by the year 2045, this will rise to 151 million. As a result, these statistics of diabetic population around the world are estimated to play as a valuable factor behind the growth of the market during the forecast period.

Increase in the Geriatric Population

The increase in the geriatric population is contributing to the increase in the diabetic population across the world due to the hormonal changes and impaired glucose regulation that takes place as a person gets old over the years. According to the National Institute of Health (NIH), older population across the globe is expected to grow in an unprecedented manner. 8.5% of the total world population (617 million) are aged 65 and over. According to the latest report, this percentage is anticipated to increase approximately 17% of the total worldwide population by the year 2050 (1.6 billion). Therefore, this growth in the diabetic population with respect to the rising rate of elderly people across the globe is estimated to augment the growth of the market over the forecast period.

Restraints

Cost Constraints

Diabetes monitoring devices are very expensive and not at all economical for most people as they need to be replaced after every 8-10 months. As it is not a financially viable option, the growth of the market might be negatively affected during the forecast period.

Market Segmentation

By Sample

• Sweat Blood
• Urine
• Others

By Product Type

• Point Sample Test Based Glucose Monitors
• Continuous Glucose Monitoring Devices
• Self-Monitoring Devices
• Enzyme Free Sensor Based Glucose Monitors

By Components

• Glucose Test Strips
• Lancet
• Sensors

By End Users

• Hospitals
• Diagnostic Clinics
• Home

By Region

On the basis of regional analysis, the global diabetes monitor market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

North America is anticipated to lead the market owing to large population of patients and high healthcare expenditure. As the prevalence of diabetes is increasing, governments and other organizations are actively participating to improve its treatment methods. Further, Europe is expected to hold the second position in the overall market of diabetes monitors due to higher investment in the research and development along with boom in technology advancement in the field of diabetes. Furthermore, Asia Pacific region is also expected to show a faster growth on the back of growing number of diabetic patients and increasing technological innovations across the region.

Global diabetes monitor market is further classified on the basis of region as follows:

• North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
• Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating The Market

• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Medtronic
• LifeScan Inc.
•  Sanofi
• Dexcom Inc.
• Abbott Laboratories
• B. Braun Melsungen
• Nova Biomedical
• Novo Nordisk A/S
• Terumo Corporation